Status:
COMPLETED
Oral Care With Colostrum for Preventing Late-onset Sepsis in Preterm Infants
Lead Sponsor:
General Organization for Teaching Hospitals and Institutes
Conditions:
Prematurity
Eligibility:
All Genders
1-24 years
Phase:
NA
Brief Summary
This clinical trial aimed to evaluate the efficacy of the oral mother's colostrum administration for preventing late-onset sepsis in premature neonates during their stay in the neonatal intensive care...
Detailed Description
The study was a randomized clinical trial, performed on very-low-birthweight premature newborns admitted to the neonatal intensive care unit of Mataria Teaching Hospital after considering exclusion cr...
Eligibility Criteria
Inclusion
- Very-low-birth-weight preterm newborns admitted to the neonatal intensive care unit within 24 hours after delivery
- Neonates with gestational age ≤ 34 weeks and weight ≤ 1500 grams
Exclusion
- Infants with severe gastrointestinal malformations.
- Infants with serious congenital anomalies or chromosomal abnormalities.
- Infants with signs of early-onset sepsis.
- Any contraindications for breastfeeding because of maternal conditions including active tuberculosis or AIDS, or treatment with medications excreted in breast milk.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06534632
Start Date
November 1 2022
End Date
November 1 2023
Last Update
August 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mataria Teaching Hospital
Cairo, Egypt